Combinations of flupirtine and sodium channel inhibiting substances for treating pains
AssigneeMEDA Pharma GmbH & Co. KG
InventorsIstvan Szelenyi, Kay Brune, Robert Hermann, Mathia Locher
Life of this patent
Estimating the term…
Abstract
The invention relates to pharmaceutical combinations of potassium channel openers and sodium channel inhibitors, for treating pains which are accompanied by an increase in muscle tone.
Claims9
A method of treating pain which is associated with abnormally elevated muscle tone associated with a disease or disorder, comprising administering to a patient experiencing pain which is associated with abnormally elevated muscle tone associated with a disease or disorder a combination of a therapeutically effective amount of flupirtine or a therapeutically utilizable salt thereof and a therapeutically effective amount of a sodium channel-inhibiting substance, wherein the sodium channel-inhibiting substance is of tolperisone, or a pharmaceutically utilizable salt thereof, wherein the therapeutically effective amounts are therapeutically superadditive.
Dependencies are inferred from the claim text.